The role of neoadjuvant chemotherapy in advanced Ovarian Cancer (AOC):
Avoiding ‘needless hurt’ or a Trojan horse?
- Robert Armbrust,
- Christina Fotopoulou
, - Jalid Sehouli
Christina Fotopoulou
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
Charite Universitatsmedizin Berlin - Campus Virchow-Klinikum
Author ProfileJalid Sehouli
Charite Universitatsmedizin Berlin - Campus Virchow-Klinikum
Author Profile09 Aug 2023Submitted to BJOG: An International Journal of Obstetrics and Gynaecology 10 Aug 2023Submission Checks Completed
10 Aug 2023Assigned to Editor
10 Aug 2023Review(s) Completed, Editorial Evaluation Pending
21 Aug 2023Editorial Decision: Revise Minor
22 Aug 20231st Revision Received
23 Aug 2023Submission Checks Completed
23 Aug 2023Assigned to Editor
23 Aug 2023Review(s) Completed, Editorial Evaluation Pending
21 Oct 2023Editorial Decision: Accept